共 9 条
[1]
Gruntzig A., Kuhlmann U., Vetter W., Treatment of renovascular hypertension with percutaneous transluminal dilatation of a renal-artery stenosis, Lancet, 1, 8068, pp. 801-802, (1978)
[2]
Isles C.G., Robertson S., Hill D., Management of renovascular disease: a review of renal artery stenting in ten studies, QJM, 92, 3, pp. 159-167, (1999)
[3]
Kuhlmann U., Greminger P., Gruntzig A., Long-term experience in percutaneous transluminal dilatation of renal artery stenosis, Am J Med, 79, 6, pp. 692-698, (1985)
[4]
Ramsay L.E., Waller P.C., Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series, Br Med J, 300, 6724, pp. 569-572, (1990)
[5]
Cooper C.J., Murphy T.P., Cutlip D.E., Stenting and medical therapy for atherosclerotic renal-artery stenosis, N Engl J Med, 370, 1, pp. 13-22, (2014)
[6]
Bax L., Woittiez A.J., Kouwenberg H.J., Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial, Ann Intern Med 150(12), 840-848, pp. 150-151, (2009)
[7]
Wheatley K., Ives N., Gray R., Revascularization versus medical therapy for renal-artery stenosis, N Engl J Med, 361, 20, pp. 1953-1962, (2009)
[8]
Kalra P.A., Guo H., Kausz A.T., Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis, Kidney Int, 68, 1, pp. 293-301, (2005)
[9]
Bittl J.A., Treatment of atherosclerotic renovascular disease, N Engl J Med, 370, 1, pp. 78-79, (2014)